Trial Profile
IV Keppra in the emergency department for prevention of early recurrent seizures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2016
Price :
$35
*
At a glance
- Drugs Fosphenytoin (Primary) ; Levetiracetam (Primary) ; Phenytoin (Primary)
- Indications Tonic-clonic epilepsy
- Focus Therapeutic Use
- 08 Dec 2008 Actual patient number (158) added as reported by ClinicalTrials.gov.
- 08 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 08 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.